Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IOM Calls For More Government Oversight Of Health IT

Executive Summary

The Institute of Medicine offers a series of recommendations to HHS to enhance the agency’s oversight of health IT, and calls on the private sector to be more engaged in sharing safety data with both the public and private sectors.

You may also be interested in...

Health IT’s Potential Patient Safety Risks Draws House Panel’s Letter To HHS

Healthcare and Technology subcommittee chairman prods HHS to describe how it will monitor health information technology to reduce risks to patient safety; the Institute of Medicine recently called for more such government oversight.

CMS Pays Out $2.5 Billion In Electronic Health Record Incentives In 2011

The HHS Office of the National Coordinator for Health Information Technology expects adoption and meaningful use to continue to grow in 2012 as it prepares to address recommendations from a November IoM report.

Downloading Confusion: Are Mobile Drug Dose Calculators Medical Devices?

Biopharmaceutical companies are expressing concern that a recent FDA draft guidance on mobile applications could force drug firms offering apps such as drug dose calculators to register and be regulated as medical device manufacturers.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts